Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aurinia Pharmaceuticals (DE:IKAP)
FRANKFURT:IKAP
RESEARCH TOOLSreports
Aurinia Pharmaceuticals (IKAP) Ownership - Who Owns Aurinia Pharmaceuticals?
1 Followers
Aurinia Pharmaceuticals (IKAP) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.18% Other Institutional Investors
99.82% Public Companies and
Individual Investors
The ownership structure of Aurinia Pharmaceuticals (DE:IKAP) stock is a mix of institutional, retail and individual investors. Approximately 0.18% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2024 | Peter Greenleaf Ceo,director | Sold | $711094 |
| Mar 07, 2024 | Sold | $194942 | |
| Mar 07, 2024 | Matthew Maxwell Donley Evp, Ops & Strategy | Sold | $224064 |
| Mar 07, 2024 | Stephen P. Robertson Evp & Gc | Sold | $323372 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 259,162 | Insider | ― | 1,165,970 | |
| 334,431 | Insider | ― | 1,504,605 | |
| 12,800,039 | Insider | ― | 57,587,375 | |
| 90,953 | Insider | ― | 409,198 | |
| 3,800 | Insider | ― | 17,096 | |
| 129,100 | Insider | ― | 580,821 | |
| 1,134,995 | Insider | ― | 5,106,343 | |
| 625,000 | Insider | ― | 2,811,875 | |
| 12,233 | Insider | ― | 55,036 | |
| 19,733 | Insider | ― | 88,779 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,923 | Institution | ― | 95,929 | |
| 5,300 | Institution | ― | 25,520 | |
| 9,128 | Institution | ― | 43,951 | |
| 123,783 | Institution | ― | 596,015 | |
| 58,015 | Institution | ― | 279,342 | |
| 28,200 | Institution | ― | 135,783 | |
| 545,484 | Institution | ― | 2,626,505 | |
| 461,866 | Institution | ― | 2,223,885 | |
| 4,731 | Institution | ― | 22,780 | |
| 54,324 | Institution | ― | 261,570 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aurinia Pharmaceuticals (DE:IKAP)?
According to the latest TipRanks data, approximately 0.18% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.82% is held by retail investors.
What percentage of Aurinia Pharmaceuticals (DE:IKAP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.18% of Aurinia Pharmaceuticals (DE:IKAP) stock is held by institutional investors.
What percentage of Aurinia Pharmaceuticals (DE:IKAP) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.82% of Aurinia Pharmaceuticals (DE:IKAP) stock is held by retail investors.
Who owns the most shares of Aurinia Pharmaceuticals (DE:IKAP)?
Michael Robert Martin owns the most shares of Aurinia Pharmaceuticals (DE:IKAP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.